Phenylephrine PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Phenylephrine PCD pharma franchise company offering 41 Phenylephrine formulations across Cream, Drop, Eye Drops, Softgel, Suspension, Syrup, Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Phenylephrine?
Phenylephrine is a selective alpha-1 adrenergic receptor agonist. By stimulating alpha-1 receptors it constricts blood vessels, which reduces swelling of the nasal mucosa when given systemically or topically, and dilates the pupil when instilled in the eye. It is used chiefly as a nasal decongestant, as a mydriatic in ophthalmology, and — in injectable form — as a vasopressor to raise blood pressure. See the compound record on PubChem.
Phenylephrine Range Available for Franchise
Our Phenylephrine portfolio comprises 41 formulations available in the following dosage forms: Cream, Drop, Eye Drops, Softgel, Suspension, Syrup, Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Phenylephrine price list and stock position.
Therapeutic Applications of Phenylephrine
Phenylephrine is used for nasal and sinus congestion associated with the common cold, allergic rhinitis and sinusitis (typically in fixed-dose cough-and-cold combinations with antihistamines, antitussives and paracetamol), for pupil dilation before ophthalmic examination, and in topical preparations for symptomatic relief of haemorrhoids. Prescribers include ENT specialists, paediatricians, general physicians, ophthalmologists and pulmonologists.
Why Phenylephrine is a High-Potential Molecule for Distributors
Phenylephrine is the backbone of the Indian cough-and-cold segment, which is one of the largest and most consistently prescribed therapeutic categories in the country. Its real commercial strength is combinability: it appears in dozens of fixed-dose combinations across syrups, drops, softgels and tablets, which is exactly why our own portfolio runs to 41 formulations. For a distributor, that breadth means one molecule covers paediatric syrups, adult tablets, nasal drops and ophthalmic drops in a single call cycle — and demand peaks predictably every winter and every change of season, giving the line a dependable annual rhythm on top of steady base volumes.
Why Choose Cafoli Lifecare for Your Phenylephrine Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Phenylephrine compound record (NIH / NCBI)
- MedlinePlus — Phenylephrine drug information (US National Library of Medicine)
- PubMed — clinical literature on Phenylephrine
Our formulations of Phenylephrine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: